Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,690 across all filing types
Latest filing 2017-10-20 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于修改《公司章程》的公告
Governance Information Classification · 95% confidence The document is an announcement regarding amendments to the company's Articles of Association (公司章程). It details changes in the board structure, specifically the number of directors and related provisions. The document references legal compliance and the need for shareholder approval at a general meeting. It is not a full report like an Annual Report or Interim Report, nor is it a certification or voting result announcement. It is a formal announcement about governance changes, specifically related to the company's internal rules and board structure. Therefore, it fits best under Governance Information (CGR). The document length is short and focused on governance amendments, not a full report or meeting materials.
2017-10-20 Chinese
关于变更监事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding a change in the company's supervisory board (监事), specifically the resignation of a supervisor and the nomination of a new candidate. It includes details about the resignation, the legal compliance, and the upcoming shareholder meeting to approve the change. There are no financial statements, earnings data, or detailed management discussion. The content fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2017-10-20 Chinese
2017年前三季度业绩预告
Earnings Release Classification · 95% confidence The document is a performance forecast for the first three quarters of 2017, providing estimated net profit growth percentages and expected profit amounts. It explicitly states that the forecast has not been audited and that detailed financial data will be disclosed in the company's third quarter report. The document is short (1039 characters) and serves as a preliminary earnings forecast rather than a full financial report. It does not contain actual financial statements or detailed analysis, only projections and explanations of expected performance. Therefore, it fits the category of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. 9M 2017
2017-10-13 Chinese
关于获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a medical device registration certificate issued by a regulatory authority (Jilin Province Food and Drug Administration). It details the product name, registration number, validity period, and clinical use. The content focuses on regulatory approval and product registration rather than financial results, management changes, or shareholder voting. The document is short (936 characters) and serves as an official announcement of a regulatory milestone rather than a financial or governance report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2017-10-11 Chinese
关于获得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company about obtaining an invention patent certificate. It includes details about the patent application, approval, and its relevance to the company's business. There is no financial data, no mention of financial results, no regulatory filings related to financial performance, no management changes, no shareholder votes, or other report types. The document is an official company announcement about intellectual property, which does not fit into any specific financial report category. Given its nature and length (619 characters), it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous company announcements that do not fit other categories.
2017-10-10 Chinese
关于公司监事辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a company supervisor (监事) and the subsequent impact on the supervisory board composition. It includes details about the resignation, the legal implications, and the process for nominating a replacement. There is no financial data, no mention of financial results, no report attached or referenced, and no indication of a meeting or voting results. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2017-09-29 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.